KBC Group NV Buys 22,978 Shares of Cigna Group $CI

KBC Group NV grew its stake in Cigna Group (NYSE:CI) by 6.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 380,034 shares of the health services provider’s stock after buying an additional 22,978 shares during the period. KBC Group NV owned approximately 0.14% of Cigna Group worth $104,768,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. PDS Planning Inc lifted its holdings in shares of Cigna Group by 15.1% during the 2nd quarter. PDS Planning Inc now owns 2,160 shares of the health services provider’s stock worth $595,000 after acquiring an additional 283 shares during the last quarter. North Dakota State Investment Board raised its position in Cigna Group by 2.6% during the second quarter. North Dakota State Investment Board now owns 7,834 shares of the health services provider’s stock valued at $2,160,000 after purchasing an additional 202 shares in the last quarter. LFG Wealth Partners LLC purchased a new stake in Cigna Group during the second quarter valued at about $1,695,000. 111 Capital bought a new stake in Cigna Group during the second quarter worth about $575,000. Finally, 71 West Capital Partners boosted its holdings in shares of Cigna Group by 32.9% in the 2nd quarter. 71 West Capital Partners now owns 1,980 shares of the health services provider’s stock worth $546,000 after purchasing an additional 490 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $282.24 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market cap of $74.58 billion, a PE ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. The business has a 50 day moving average price of $286.02 and a 200-day moving average price of $281.28.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CI shares. Cantor Fitzgerald raised their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Morgan Stanley boosted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Finally, The Goldman Sachs Group upped their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $339.45.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.